Home  »  Finance   »  Gear up for the change! Reviva Pharmaceuticals Hol...

Gear up for the change! Reviva Pharmaceuticals Holdings Inc. (RVPH) has hit the volume of 660907

For the readers interested in the stock health of Reviva Pharmaceuticals Holdings Inc. (RVPH). It is currently valued at $2.00. When the transactions were called off in the previous session, Stock hit the highs of $2.2782, after setting-off with the price of $2.24. Company’s stock value dipped to $1.96 during the trading on the day. When the trading was stopped its value was $2.26.Recently in News on September 7, 2022, Reviva Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference. Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the H.C. Wainwright Global Investment Conference being held September 12–14, 2022 and invites investors to participate via virtual one-on-one meetings or in-person in New York, NY. Please see additional details below:. You can read further details here

Reviva Pharmaceuticals Holdings Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.63 on 01/10/22, with the lowest value was $0.53 for the same time period, recorded on 08/01/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Reviva Pharmaceuticals Holdings Inc. (RVPH) full year performance was -52.04%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Reviva Pharmaceuticals Holdings Inc. shares are logging -55.65% during the 52-week period from high price, and 277.36% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.53 and $4.51.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 660907 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Reviva Pharmaceuticals Holdings Inc. (RVPH) recorded performance in the market was -30.80%, having the revenues showcasing 73.91% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 40.60M, as it employees total of 5 workers.

The Analysts eye on Reviva Pharmaceuticals Holdings Inc. (RVPH)

During the last month, 0 analysts gave the Reviva Pharmaceuticals Holdings Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.43, with a change in the price was noted -0.12. In a similar fashion, Reviva Pharmaceuticals Holdings Inc. posted a movement of -5.66% for the period of last 100 days, recording 986,523 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for RVPH is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical rundown of Reviva Pharmaceuticals Holdings Inc. (RVPH)

Raw Stochastic average of Reviva Pharmaceuticals Holdings Inc. in the period of last 50 days is set at 57.20%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 47.99%. In the last 20 days, the company’s Stochastic %K was 60.29% and its Stochastic %D was recorded 64.52%.

Considering, the past performance of Reviva Pharmaceuticals Holdings Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -30.80%. Additionally, trading for the stock in the period of the last six months notably improved by 11.73%, alongside a downfall of -52.04% for the period of the last 12 months. The shares increased approximately by -7.83% in the 7-day charts and went down by 168.46% in the period of the last 30 days. Common stock shares were driven by 73.91% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]